THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Wednesday reported a loss of $74.6 million in its fourth quarter.
The Thousand Oaks, California-based company said it had a loss of 72 cents per share.
The drug developer posted revenue of $221,000 in the period.
For the year, the company reported that its loss narrowed to $228.3 million, or $2.24 per share. Revenue was reported as $63.6 million.
Atara Biotherapeutics shares have risen 54% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.04, a decrease of 67% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.